首页> 外文会议>Asian-Pacific Congress of Hypertension >Blood pressure modulation and ROS/NO balance in young rats.
【24h】

Blood pressure modulation and ROS/NO balance in young rats.

机译:幼鼠血压调制和ROS /无平衡。

获取原文

摘要

In models of young rats we studied influence of NOS inhibitors: 7-nitroindazol (7-NI), N~G-nitro-L-arginin-metyl ester (L-NAME) and PPAR gamma agonist pioglitazone (PIO) on blood pressure and radical signaling triggered via superoxide dismutases (SOD), and NO-synthases (NOS).From NOS inhibitors only L-NAME up-regulated blood pressure in young Wistar rats. However tissue specific modulation of AT1R, SOD1 and/or SOD3 genes was observed for both inhibitors. Decrease of blood pressure in young SHR after PIO treatment was joined with tissue specific effect of this substance. Antioxidant effects of PIO were in left ventricle realized through an increase of total SOD activities. Different responses at central and peripheral level should be clarified by further investigation.
机译:在幼鼠模型中,我们研究了NOS抑制剂的影响:7-硝基吲哚(7-NI),N〜G-NITRO-L-精氨酸 - 酯(L-名称)和PPARγ激动剂Pioglitazone(PIO)对血压和通过超氧化物脱粉剂(SOD)和No-Synthase(NoS)触发的自由基信号传导。从NoS抑制剂中仅在幼小Wistar大鼠中抑制上调血压。然而,对于两种抑制剂,观察到AT1R,SOD1和/或SOD3基因的组织特异性调节。 PIO治疗后,幼小SCR血压降低与该物质的组织特异性效应。通过增加总SOD活性实现PIO的抗氧化效应在左心室中实现。通过进一步调查,应澄清中环和外围级别的不同响应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号